AVANOS MEDICAL, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avanos Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2014 to Q2 2024.
  • Avanos Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.8M, a 2.56% decline year-over-year.
  • Avanos Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $15.3M, a 4.38% decline year-over-year.
  • Avanos Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.8M, a 0.63% decline from 2022.
  • Avanos Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.9M, a 20.5% increase from 2021.
  • Avanos Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.2M, a 9.09% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $15.3M $3.8M -$100K -2.56% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $15.4M $3.6M -$400K -10% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $15.8M $4M $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $15.8M $3.9M -$200K -4.88% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $16M $3.9M -$100K -2.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $16.1M $4M +$200K +5.26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $15.9M $4M +$1M +33.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $14.9M $4.1M +$600K +17.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $14.3M $4M +$400K +11.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $13.9M $3.8M +$700K +22.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $13.2M $3M -$200K -6.25% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $13.4M $3.5M +$100K +2.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $13.3M $3.6M +$600K +20% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $12.7M $3.1M +$600K +24% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $12.1M $3.2M +$1.5M +88.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $10.6M $3.4M +$600K +21.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $10M $3M +$1.2M +66.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $8.8M $2.5M -$1.7M -40.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $10.5M $1.7M -$800K -32% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $11.3M $2.8M +$400K +16.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $10.9M $1.8M -$300K -14.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $11.2M $4.2M +$700K +20% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $10.5M $2.5M +$1.6M +178% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $8.9M $2.4M +$400K +20% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $8.5M $2.1M -$3.2M -60.4% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $11.7M $3.5M -$900K -20.5% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $12.6M $900K -$900K -50% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $13.5M $2M -$1M -33.3% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $14.5M $5.3M -$700K -11.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $15.2M $4.4M +$400K +10% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $14.8M $1.8M +$1.8M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $13M $3M $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $13M $6M $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $13M $4M -$1M -20% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $14M $0 -$3M -100% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $17M $3M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $5M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $3M Nov 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.